7MW4911

DRUG2 trials

Sponsors

Mabwell (Shanghai) Bioscience Co., Ltd.

Conditions

GI CancersSolid Tumors

Phase 1

First-in-human Study of 7MW4911 in GI Cancer

RecruitingNCT07216560

Mabwell (Shanghai) Bioscience Co., Ltd.GI Cancers

Start: 2026-01-13End: 2028-12-01Target: 200Updated: 2026-08-21

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

RecruitingNCT07265622

Mabwell (Shanghai) Bioscience Co., Ltd.Solid Tumors

Start: 2025-11-12End: 2028-12-31Target: 200Updated: 2025-12-29